ProBio's Nanjing biologics manufacturing facility completes Chinese regulatory pre-approval inspection

Lynch Regenerative Medicine's Phase IIb clinical trial of rhPDGF-BB injection cleared by FDA

European Commission approves Novartis' Cosentyx for polymyalgia rheumatica

GSK wins US FDA approval for chronic hepatitis B treatment Hibsago

Summit Therapeutics and ECOG-ACRIN launch Phase II/III trial collaboration for biliary tract cancer

RxMP Therapeutics secures DARPA contract worth up to USD10.7m

TNutra launches NeuraLegend brain health supplements

Health Canada approves AbbVie psoriasis treatment for children

WuXi AppTec recognised in Frost & Sullivan's Global Company of the Year awards for Tenth Consecutive Year

Oracle partners AstraZeneca for AI-enabled healthcare innovation

Eli Lilly and Company reports positive one-year results for Omvoh in paediatric ulcerative colitis

AbbVie's dual-targeting Crohn's disease therapy outperforms monotherapies in Phase IIa trial

Takeda trial shows ENTYVIO reduces ulcerative colitis complication risk by nearly 70%

GSK reports 61% response rate for investigational lung cancer drug

UEG introduces new Patient Representatives Advisory Board